Annual Retained Earnings
-$75.14 M
+$22.72 M+23.22%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual retained earnings is -$75.14 million, with the most recent change of +$22.72 million (+23.22%) on December 31, 2023.
- During the last 3 years, CTNM annual retained earnings has fallen by -$1.53 million (-2.08%).
- CTNM annual retained earnings is now -2.08% below its all-time high of -$73.61 million, reached on December 1, 2021.
Performance
CTNM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$102.84 M
-$10.27 M-11.09%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly retained earnings is -$102.84 million, with the most recent change of -$10.27 million (-11.09%) on September 30, 2024.
- Over the past year, CTNM quarterly retained earnings has dropped by -$27.69 million (-36.85%).
- CTNM quarterly retained earnings is now -52.63% below its all-time high of -$67.38 million, reached on September 30, 2023.
Performance
CTNM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CTNM Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.2% | -36.9% |
| 3 y3 years | -2.1% | -5.1% |
| 5 y5 years | -2.1% | -5.1% |
CTNM Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.1% | +23.2% | -52.6% | at low |
| 5 y | 5-year | -2.1% | +23.2% | -52.6% | at low |
| alltime | all time | -2.1% | +23.2% | -52.6% | at low |
Contineum Therapeutics Class A Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$102.84 M(+11.1%) |
| Jun 2024 | - | -$92.57 M(+10.8%) |
| Mar 2024 | - | -$83.56 M(+11.2%) |
| Dec 2023 | -$75.14 M | -$75.14 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$67.38 M(-31.2%) |
| Dec 2022 | -$97.86 M(+32.9%) | - |
| Dec 2022 | - | -$97.86 M |
| Dec 2021 | -$73.61 M | - |
FAQ
- What is Contineum Therapeutics Class A annual retained earnings?
- What is the all time high annual retained earnings for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual retained earnings year-on-year change?
- What is Contineum Therapeutics Class A quarterly retained earnings?
- What is the all time high quarterly retained earnings for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly retained earnings year-on-year change?
What is Contineum Therapeutics Class A annual retained earnings?
The current annual retained earnings of CTNM is -$75.14 M
What is the all time high annual retained earnings for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual retained earnings is -$73.61 M
What is Contineum Therapeutics Class A annual retained earnings year-on-year change?
Over the past year, CTNM annual retained earnings has changed by +$22.72 M (+23.22%)
What is Contineum Therapeutics Class A quarterly retained earnings?
The current quarterly retained earnings of CTNM is -$102.84 M
What is the all time high quarterly retained earnings for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly retained earnings is -$67.38 M
What is Contineum Therapeutics Class A quarterly retained earnings year-on-year change?
Over the past year, CTNM quarterly retained earnings has changed by -$27.69 M (-36.85%)